Although DNA analysis based on the polymerase chain reaction (PCR) offers potential advantages for screening newborns for sickle cell disease, few data are available concerning the reliability of PCR-based tests for such screening. We describe a protocol for detecting the A, S, and C alleles of the /3-globin gene in dried blood from phenylketonuria screening cards. This method is based on PCR and detection with allele-specific oligonucleotide probes. Results of a blind comparison of PCR analysis of the dried blood with hemoglobin electrophoresis of wholeblood samples agreed for 80 of 81 samples. The single discrepancy is probably not attributable to a failure of the PCR method, but rather to limitations of the electrophoresis method. The PCR method should be a highly accurate means of detecting /3-globin alleles in routine genetic screening with dried blood already collected for (e.g.) pheriylketonuria screening.
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Received November 5, 1990 ; accepted January 10, 1991. The polymerase chain reaction (PCR) (1, 2) has been used in combination with allele-specific oligonucleotide (ASO) probes (3) for diagnosis of several genetic diseases caused by point mutations, including sickle cell disease (4) . Mass neonatal screening for sickle cell disease is important because early identification and treatment of infants with sickle celldisease improves survival (5, 6 diagnosis of such diseases as sickle cell disease (7) , phenylketonuria (8) , cystic fibrosis (9, 10) , and Duchernie muscular dystrophy (10) . However, those studies have not included a systematic evaluation ofthe suitability of the methods for routine clinical testing.
Clinical experience with routinePCR-ASO testing of DNA islimited, and few data are available evaluating the performance of this method as a mass screening assay. Although in theory the method is expected to be highly accurate, actual performance in routine use could be degraded by such problems as inadequate specimens, contamination of the specimen or the PCR, or poor reproducibility of the washing procedures required for detecting a single base mismatch.
We have developed a PCR-ASO protocol for detection of the 13-globin A, S, and C alleles in DNA extracted from Guthrie cards. We also performed a blind evaluation of the analytical performance of this method on patients' samples compared with that of the standard screening method, hemoglobinelectrophoresis.
Materials and Methods

Study Population and Specimens
Anonymous specimens were obtained from a voluntary screening program offered by the Washington State Health Laboratory.
Physicians desiring hemoglobin screening fortheirnewborn patients senta whole-blood sample (five toseven 100-ML capillary tubes containing heparinized whole blood) to the laboratory for evaluation. These blood samples were evaluated forthe presence of abnormal hemoglobins by standard methods of cellulose acetate and citrate agar electrophoresis of hemoglobin (11). Guthrie card specimens were also obtained for all these infants by standard methods as part of routine screening forothergenetic disorders. The corresponding Guthrie cards for 81 patients were selected and subjected to blinded DNA analysis, with no knowledge of the electrophoresis results before the DNA analysis and interpretation. The population for DNA analysis was selected so that the percentage of specimens with abnormal hemoglobin findings was greater than that normally found in the voluntary screening population. The ethnic background ofpatients forwhom samples were submitted varied, but the subjects were predominantly infants at increased risk for hemoglobinopathies. The Guthrie cards had been collected no more than three months before being subjected to DNA analysis.
DNA Preparation
DNA was prepared from the Guthrie cards as described (9) . About one quarter of one spot from each Guthrie card (-12 pL of whole blood) was removed via a standard (0.25-in.-diameter) metal paper punch and digested in 500 p.L of a solution of 2 g of proteinase K and 5 g of sodium dodecyl sulfate per liter for 2 h at 60#{176}C. The metal hole punch was rinsed for5 mm in 0.25 mol/L HC1 solution between each use to prevent crosscontamination of samples. Several hole punches were used alternately to expedite the procedure. The digest was extracted three times with 500 ML of an equivolume solution of chloroform/buffered phenol, followed by a single extraction with 500 ML ofchloroform. The DNA was precipitated by adding NaCl (final concentration, 0.4 moIJL) and 1.5 mL of cold 100% ethanol, and then was centrifuged at 10 000 x g for 5 mm. The ethanol was removed and the pellet dried in a heated centrifuge (37 #{176}C) for 15 mm. The DNA was dissolved in 50 ML of a buffer consisting of, per liter, 10 mmol of Tris -HC1 (pH 7.6), 10 mmol of NaCl, and 1 mmol of EDTA.
We used this extraction protocol because we found that simpler methods of DNA isolation from Guthrie cards yielded substantially higher rates of failure of amplification by PCR. To estimate the amount of DNA recovered in Guthrie card specimens from five newborns, we used fluorescence quantification (12) with calf thymus DNA as a standard.
DNA Amplification Table 1 summarizes the oligonucleotide probes (3) and primers (4) used. "Anti-sense" ASO probes were used because we previously found that they give a sevenfold greater signal than do "sense" probes in this particular assay (13) . The PCR primers amplify a 298-hp fragment of the /3-globin gene that extends from nucleotide -40 through the first exon to nucleotide 258 (inthe first intervening sequence) (14) . PCR was performed as described (15); reaction mixtures consisted of 2.5 ML of the Guthrie card extract, 20 pmol of each primer, 4 nmol of each deoxynucleotide triphosphate (dNTP), MgC12 at 1.5 mmol/L, Tris -HC1 (pH 8.3)at 10 mmol/L, KC1 at 50 mmol/L, gelatin at 0.1 g/L, and 0.8 units of Taq polymerase (AnipliTaq; Perkin-Elmer Cetus, Emeryville, CA) in a total reaction volume of 20 ML. PCR reactions were set up in sterile 600-ML tubes topped off with 20 LL of mineral oil to prevent evaporation. To prevent contamination of the PCR, we prepared the reactions in a room where PCR products and plasmid preparation and analysis were prohibited; reactions were prepared with gloved hands and pipettes used only for that purpose. PCR was performed in a DNA Thermal Cycler (Perkin- Elmer Cetus, Norwalk, CT) in a step-cycle mode with thefollowing conditions: 6 mm at 94 #{176}C; 35 cycles, each consisting of1 mm at94 #{176}C, 2 mm at55 #{176}C, and 2 mm at 72 #{176}C; and 10 mm at 72#{176}C.
Hybridization Analysis of PCR Products
Using pipettesdedicated for use only with PCR products, we denatured 3 ML of the PCR reactionproduct with 0.3 ML of 4 mol/L NaOH containingsalmon sperm DNA (Sigma Chemical Co.), 1 g/L, added to increase the intensity and uniformity of the hybridizationsignal. After letting this solution stand at room temperature for 15 mm, we applied 3 ML of it with a pipette to a dry nylonmembrane (GeneScreen-Plus; Du PontNEN, Boston, MA). Membranes were air-dried at room temperature for 30 mm, or at 37 #{176}C for 15 mm. The negative extraction controlappliedto each membrane was the extraction product from a blank Guthrie card taken through the PCR procedure. 
Results
Optimization of the PCR-ASO Procedure
Typical results of the PCR-ASO dot-blot method for detection of the A, 5, and C alleles of the /3-globin gene are shown in Figure 1 . Washing at 45 #{176}C provided excellent discrimination forallthreealleles. Reproducibly, the hybridization signals from the HB19A' and HB19S' probes were equivalent and greater than that from HB19C'. This difference was probably attributable to the lower GC content of HB19C' relative to the other We found that the hybridization solution containing labeled ASO probe could be frozen at -20 #{176}C and re-used for up to four weeks with excellent results. The success of this approach indicates that frequent probe labeling is unnecessary, minimizing the cost of using labeled ASO probes.
The method involved the use of about one quarter of a Guthrie card blood spot; the average amount of DNA extracted was found to be 740 ± 370 ng (range 530-1395 ng). Only 5% of the DNA extracted from each sample was used, corresponding to an average of 37 ng per PCR amplification. This provided sufficient sample for repeat analysis or additional follow-up. The hybridization signal from various quantities of the pUC/3 plasmid varied linearly with the amount applied, from 2 to 20 fmol (13) . Although the size of the plasmid was larger than the generated PCR fragment, the hybridization signalcan be used to estimate thatthe molar detectability of the dot-blot method is on the order of 2 fmol of plasmid DNA when a 2-h autoradiographicexposure is used. The PCR product (3 ML) from amplification of a typical Guthrie card sample produced a signal comparable with the signal from 25 fmol of plasmid DNA. We determined that the denatured PCR product with added salmon sperm DNA could be applied directly to the dry nylon membrane without the use of a suction manifold. Adequate signals were obtained without further treatment of the membranes (e.g., baking or exposure to ultraviolet radiation).
Correlation with Hemoglobin Electrophoresis
The Guthrie card samples in this study were evaluated in seven runs over a six-month period. Of the 81 specimens evaluated, only two gave insufficient signal on the first run, requiring repeat analysis. Sufficient signal on these samples was obtained by simply repeating the PCR amplification and hybridization without any modifications to the existing procedure. After the blinded interpretation of the DNA results, we compared
The primary reason for clinically screening these newborn patients was toidentify infants with sickle cell disease. In this respect, the PCR-ASO method performed well, detecting the S allele correctly in all subjects. However, in the samples studied, hemoglobin electrophoresis detected more abnormalities than the presentPCR-ASO method. If early identification of individuals with hemoglobins E and Constant Spring offers an opportunity for improved clinical treatment, DNA screeningcouldbe readilyadapted to accommodate these additional tests. The detection of Bart's hemoglobin by electrophoresismay also provide a means of identifying newborns with a-thalassemia, but the clinical utility of this early finding may not be significant.
When addressing the advantages of electrophoresis relative to the PCR-ASO method, it is important to consider the electrophoretic separation of hemoglobins A and F. Because this separation is not very distinct, the Likewise, the PCR-ASO method may be useful for identifying infants with S orC trait and /3#{176}-thalassemia. By electrophoresis, these infants would appear to have sickle cell or hemoglobin C disease because of the lack of hemoglobin A. However, because the sequence detected by HB19A' is still intact, the ASO-PCR dot-blot would be positive for the A and the S or C allele. Although one would not need both techniques forallsamples,DNA analysis combined with electrophoresis would provide an accurate early diagnosis without requiring the parental samples needed for diagnoses based solely on hemoglobinelectrophoresis.
We find the ASO-PCR method to be a reliable technique for identifying sickle cell disease in newborns. At present, it probably costs more than hemoglobin electrophoresis; however, it has the potential for substantial cost reductions through the use of automated DNA preparation, higher sample throughput, and amenabil- the results for each Guthrie card with the corresponding electrophoresis findings for cord blood hemoglobin. Comparison of PCR-ASO dot-blot and electrophoresis results provides an indication of the accuracy of each method. However, because this PCR-ASO method detects only the presence of A, S, or C alleles in the sixth codon of the /3-globin gene, whereas electrophoresis detects a much larger variety of protein products, complete correlation is not expected. For example, electrophoresis is able to identifr several hemoglobmns, including E, F, Bart's, Constant Spring, and fast-moving unidentified proteins, findings that were not identifiable with the DNA probes used in this study.
After taking account of the differences in the two methods, the PCR-ASO dot-blot and electrophoresis results agreed completely for 80 of 81 patients ( Table 2 ). The single discrepancy may be due to a problem in the original electrophoretic analysis of the cord blood sample. Additional analysis of the Guthrie card specimen by isoelectric focusing demonstrated the presence of hemoglobins F, A, and C, confirming the DNA analysis; likewise, DNA analysis of the cord blood sample demonstrated A and C alleles. One possibility is that the electrophoresis was not able to adequately differentiate the similarly migrating hemoglobin A and F, so that the former was not visible by that method. The confirmation of PCR results by isoelectric focusing excluded an alternative possibility that a /3-thalassemia mutation, outside of the region probed by the ASO, prevented the production of hemoglobin A (so that it could not be detected by electrophoresis).
DIscussIon
This study shows that the PCR-ASO method is highly accurate in detecting /3-globin alleles in routine neonatal genetic screening of samples from Guthrie cards. The reliability of the DNA method, as detailed in Results, suggests that errors due to contamination of the PCR or to difficulty in standardizing wash conditions must be rare. (1-4) . Two different forms of SOD predominate in humans, manganese-containing dismutase (Mn-SOD) and copper/zinc-containingdismutase (Cu,Zn-SOD). Mn-SOD is locatedmainly in the matrix of mitochondria, whereas Cu,Zn-SOD is found in the cytoplasm of eukaryotic cells(5-7). Mn-SOD, an 80-kDa tetramer of 196 amino acid residues, is present in high concentration in liver, heart, kidney, and adrenal gland (8) (9) (10) (11) . Heart muscle is rich in Mn-SOD, which is present mainly in the mitochondria.
We hypothesized thatthe Mn-SOD concentrationin serum may change in abbreviations:
SOD, superoxide dismutase; CK-MB, creatine kinase isoenzyme MB; AMI, acute myocardial infarction; AP, angina pectoris; and LDH, lactate dehydrogenase.
